218.12

0.00% -0.06

After Hours: 217.95 -0.17 -0.08%

West Pharmaceutical Services Inc (WST)

Overview News Price History Option Chain Financials Why WST Down? Discussions Forecast Stock Split Dividend History

West Pharmaceutical Services Inc stock is traded at $218.12, with a volume of 406.22K. It is down -0.00% in the last 24 hours and up +0.65% over the past month. West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Previous Close:

$218.06

Open:

$217.89

24h Volume:

406.22K

Relative Volume:

0.51

Market Cap:

$16.36B

Revenue:

$2.90B

Net Income/Loss:

$467.20M

P/E Ratio:

34.24

EPS:

6.37

Net Cash Flow:

$306.90M

1W Performance:

-2.66%

1M Performance:

+0.65%

6M Performance:

-32.97%

1Y Performance:

-32.30%

1-Day Range:

$216.29

$220.66

1-Week Range:

$216.29

$226.54

52-Week Range:

$187.43

$352.33

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name

West Pharmaceutical Services Inc

Sector

Healthcare (1173)

Industry

Medical Instruments & Supplies (60)

Phone

(610) 594-2900

Address

530 HERMAN O. WEST DRIVE, EXTON, PA

Employee

10,600

Twitter

@WestPharma

Next Earnings Date

2024-10-24

Latest SEC Filings

WST's Discussions on Twitter

Compare WST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WST West Pharmaceutical Services Inc	218.12	16.36B	2.90B	467.20M	306.90M	6.37
ISRG Intuitive Surgical Inc	509.35	189.82B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	168.63	49.98B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	84.74	44.00B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	250.87	37.05B	5.02B	1.31B	1.56B	8.91

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-18-25	Initiated	Evercore ISI	Outperform
Feb-14-25	Upgrade	Deutsche Bank	Hold → Buy
Jan-08-25	Initiated	Citigroup	Buy
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-12-24	Upgrade	UBS	Neutral → Buy
Feb-07-24	Upgrade	Jefferies	Hold → Buy
Jun-16-23	Upgrade	BofA Securities	Neutral → Buy
Apr-11-23	Upgrade	Stephens	Equal-Weight → Overweight
Dec-14-22	Initiated	Deutsche Bank	Hold
Nov-30-22	Initiated	UBS	Neutral
Oct-28-22	Downgrade	BofA Securities	Buy → Neutral
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Oct-14-20	Initiated	Stephens	Equal-Weight
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Apr-24-20	Upgrade	BofA/Merrill	Underperform → Neutral
Dec-12-19	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-19	Upgrade	BofA/Merrill	Underperform → Neutral
May-01-19	Downgrade	Jefferies	Buy → Hold
Apr-23-19	Initiated	William Blair	Outperform
Apr-25-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-24-18	Initiated	Goldman	Neutral
Oct-17-17	Downgrade	BofA/Merrill	Buy → Neutral
Oct-03-17	Initiated	Stephens	Equal-Weight
Sep-15-17	Upgrade	Jefferies	Hold → Buy
Oct-28-16	Upgrade	Wells Fargo	Market Perform → Outperform
Sep-21-16	Downgrade	Wells Fargo	Outperform → Market Perform
Mar-22-16	Initiated	Wells Fargo	Outperform
May-14-10	Reiterated	UBS	Neutral
Feb-23-10	Initiated	Jefferies & Co	Buy
Dec-19-08	Initiated	UBS	Neutral

View All

West Pharmaceutical Services Inc Stock (WST) Latest News

11:30 AM

KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth - Investing.com

11:30 AM

10:56 AM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming DeadlinesWST - FinancialContent

10:56 AM

10:52 AM

Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline - ACCESS Newswire

10:52 AM

07:13 AM

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - Morningstar

07:13 AM

Jun 17, 2025

WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jun 17, 2025

WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

Jun 17, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - StreetInsider

Jun 17, 2025

Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Reminds Investors of July 7, 2025 - ACCESS Newswire

Jun 17, 2025

Is West Pharmaceutical Services Stock Underperforming The Nasdaq? - Barchart.com

Jun 17, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders - PR Newswire

Jun 17, 2025

Jun 16, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm - Morningstar

Jun 16, 2025

2025-06-16 | Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action | NYSE:WST | Press Release - Stockhouse

Jun 16, 2025

Deadline Alert: West Pharmaceutical Services, Inc. (WST) - GlobeNewswire

Jun 16, 2025

Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView

Jun 16, 2025